Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

PCRXPCRX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in PACIRA BIOSCIENCES INC

JPMORGAN CHASE & CO holds 346,697 shares of PCRX (PACIRA BIOSCIENCES INC), worth $8.7M as of 2026-Q2. The position was increased (+44.2% shares). PCRX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$8.7M

Current Shares

346,697

Total Value Change

-$5.5M

Total Shares Change

-409,479

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
346,697
+44.2%
$8.7M0.0%$25.37
37
2026-Q1
Decreased
240,369
-16.7%
$5.6M0.0%$22.10
0
2025-Q4
Decreased
288,651
-66.9%
$7.5M0.0%$26.07
0
2025-Q3
Increased
872,396
+155.1%
$22.5M0.0%$25.34
46
2025-Q2
Decreased
342,006
-47.6%
$8.2M0.0%$23.48
0
2025-Q1
Decreased
652,476
-13.7%
$16.2M0.0%$24.91
0
2024-Q4
New
756,176
-
$14.2M0.0%$18.94
39

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used